1-8 of 8
J Ritter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia

Tasha L. Lin, Alexander J. Ritter, Amit K. Jaiswal, Jenna Reppas, Tiffany M. Tran, Zachary T. Neeb, Sol Katzman, Michelle Thaxton, Amanda Cohen, Jeremy R. Sanford, Dinesh S. Rao
Journal: Blood
Blood (2023) 142 (Supplement 1): 5692.
https://doi.org/10.1182/blood-2023-174813
Published: 2023
Journal Articles

Overall Survival Disparities in Metro/Urban/Rural Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Andrew J. Ritter, Jordan S. Goldstein, BS, Anh Thuy Phan, MPH, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4159.
https://doi.org/10.1182/blood.V130.Suppl_1.4159.4159
Published: 2017
Journal Articles

Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87

U Creutzig, J Harbott, C Sperling, J Ritter, M Zimmermann, H Loffler, H Riehm, G Schellong, WD Ludwig
Journal: Blood
Blood (1995) 86 (8): 3097–3108.
https://doi.org/10.1182/blood.V86.8.3097.3097
Published: 1995
Journal Articles

Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and M3 variant) in childhood [letter]

A Cantu-Rajnoldi, A Biondi, M Jankovic, G Masera, A Rovelli, C Uderzo, D Head, S Raimondi, V Creutzig, J Ritter
Journal: Blood
Blood (1993) 81 (8): 2209–2210.
https://doi.org/10.1182/blood.V81.8.2209.2209
Published: 1993
Journal Articles

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group

A Reiter, M Schrappe, WD Ludwig, F Lampert, J Harbott, G Henze, CM Niemeyer, H Gadner, S Muller-Weihrich, J Ritter
Journal: Blood
Blood (1992) 80 (10): 2471–2478.
https://doi.org/10.1182/blood.V80.10.2471.2471
Published: 1992
Journal Articles

Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group

U Creutzig, J Ritter, G Schellong
Journal: Blood
Blood (1990) 75 (10): 1932–1940.
https://doi.org/10.1182/blood.V75.10.1932.1932
Published: 1990
Journal Articles

Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis

WD Ludwig, CR Bartram, J Ritter, A Raghavachar, W Hiddemann, G Heil, J Harbott, H Seibt-Jung, JV Teichmann, H Riehm
Journal: Blood
Blood (1988) 71 (6): 1518–1528.
https://doi.org/10.1182/blood.V71.6.1518.1518
Published: 1988
Journal Articles

Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78

U Creutzig, J Ritter, H Riehm, HJ Langermann, G Henze, H Kabisch, D Niethammer, H Jurgens, B Stollmann, U Lasson
Journal: Blood
Blood (1985) 65 (2): 298–304.
https://doi.org/10.1182/blood.V65.2.298.298
Published: 1985